Piramal Pharma Announces Completion of 20% Strategic Growth Investment by Carlyle
PEL raises funds of ~INR 14,500 Crores in FY2020
Built on the foundation of Trusteeship, Piramal Group imbibes a business ethos that believes in creating value for all its stakeholders.
Committed to its corporate philosophy of ‘Doing Well and Doing Good’, Piramal Group is focused on building innovative solutions that positively impact the larger community.
Ranked Amongst“India’s 30 Best Workplaces in Manufacturing - 2020”
Delighted to partner with NITI Aayog and launch “Surakshit Dada Dadi Nana Nani Abhiyaan” in 112 Aspirational Districts across India
Piramal Enterprises Limited Announces Consolidated Results for Q1 FY2021 ended June 30, 2020 Read More
Piramal Pharma Solutions Announces Integrated Development Program with Bolt Biotherapeutics for Immune-Stimulating Antibody Conjugates and Sterile Fill-Finish Read More
Piramal Critical Care Announces Strategic Partnership with US-Based Pharmaceutical Outsourcing Facility - Medivant Healthcare Read More
PEL - Proceedings of the 73rd Annual General Meeting
Mr. Ajay Piramal in conversation with CNBC International on the investment by Carlyle Group in Piramal's Pharma business
Partnerships to Advance Public Health & the Economy in the COVId-19 Era | Webinar Co-hosted by Piramal Foundation, Harvard T.H. Chan School of Public Health & Project Sanchar
@PiramalFdn continues to support the Government in its fight against #COVID_19 pandemic. Our @ADTPiramal tea...Read Here
Committed to providing excellence in pharma and financial services
World-class developments that nurture thriving communities
Setting new benchmarks in world glass packaging solutions
© 2020 Piramal Enterprises Ltd.